Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| 22nd Century Group, Inc.XXII · Entity 8519 | Senior VP-Science & Regulatory | October 31, 2017 | November 08, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
22nd Century Group, Inc.
Report date October 31, 2017 · Filed November 08, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.12 · Expires 2027-10-31 | Direct | 900,000 |
Reported balance
After 2017-10-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-10-31 · Grant · Acquired 900,000 · Balance 900,000 F1: Vests one-third on each of November 1, 2018, November 1, 2019 and November 1, 2020. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.12 · Expires 2027-10-31 | Direct | 300,000 |
Reported balance
After 2017-10-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-10-31 · Grant · Acquired 300,000 · Balance 300,000 F2: Vests upon the satisfaction of certain performance conditions. |
Filing footnotes · ownership attribution and instrument terms
F1: Vests one-third on each of November 1, 2018, November 1, 2019 and November 1, 2020.
F2: Vests upon the satisfaction of certain performance conditions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 31, 2017 Filed Nov 8, 2017 22:20 UTC | 22nd Century Group, Inc. XXII · Entity 8519 | GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001140361-17-041623 · doc1.xml · derivative · entry 2 Swauger James E. · CIK 0001722086 · Senior VP-Science & Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2027-10-31 F2 · derivative.exercise_date: Vests upon the satisfaction of certain performance conditions. Read SEC document |
| October 31, 2017 Filed Nov 8, 2017 22:20 UTC | 22nd Century Group, Inc. XXII · Entity 8519 | GrantStock Option (Right to Buy) · Derivative | 900,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001140361-17-041623 · doc1.xml · derivative · entry 1 Swauger James E. · CIK 0001722086 · Senior VP-Science & Regulatory 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900,000 Underlying: Common Stock · 900,000 shares Expires 2027-10-31 F1 · derivative.exercise_date: Vests one-third on each of November 1, 2018, November 1, 2019 and November 1, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.